🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Activist investor Starboard Value takes $1 bln stake in Pfizer - WSJ

Published 10/06/2024, 08:35 PM
Updated 10/07/2024, 04:16 AM
© Reuters
PFE
-

Investing.com-- Activist investor Starboard Value has taken an around $1 billion stake in Pfizer Inc (NYSE:PFE) and wants the drugmaker to make sweeping changes to turn around laggard performance, the Wall Street Journal reported on Sunday. 

Starboard has approached two former Pfizer executives -- Ian Read and Frank D’Amelio -- who have in turn expressed interest in helping, the WSJ report said. Read was Pfizer's former CEO, while D’Amelio was its CFO until 2021. 

Pfizer benefited greatly from a soaring need for its vaccine during the COVID-19 pandemic. But demand has cooled over the past two years, while its earnings and share price performance have disappointed investors. 

The firm was also accused of lacking discipline in its pandemic-era dealmaking, and has lagged its rivals Eli Lilly and Company (NYSE:LLY) and Novo Nordisk (NYSE:NVO) in rolling out highly popular weight loss drugs. In late-2023, Pfizer issued a revenue warning and a disappointing 2024 outlook, along with a $3.5 billion cost-cutting drive.

Shares in Pfizer, which are now trading below pre-pandemic levels, were higher prior to the opening bell on Wall Street on Monday following the report.

In a note to clients, analysts at BMO Capital Markets said that thye have "sensed investor frustration" with Pfizer CEO Albert Bourla since at least the beginning of 2023, although they flagged that dismissing him "is unlikely to fix the story and immediately re-rate shares."

"We understand why an activist might think that Pfizer is the right story to get involved in, but management appears to actually be undertaking many of the corrective actions to right the ship," they argued. "Staying the course and focus is usually the right answer in the long-run."

Starboard had also recently taken a stake in Starbucks (NASDAQ:SBUX) with an aim to boost the coffee giant's share price. It has also been active in the technology sector.

(Ambar Warrick contributed reporting.)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.